wr 1065 has been researched along with Leukemia L5178 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antoku, S | 1 |
| Evans, HH; Horng, MF; McCoy, EC; Ricanati, M | 1 |
| Evans, HH; Evans, TE; Horng, MF | 1 |
3 other study(ies) available for wr 1065 and Leukemia L5178
| Article | Year |
|---|---|
Protection of cultured mammalian cells by S-2-(3-aminopropylamino)ethylphosphorothioic acid(WR-2721).
Topics: Amifostine; Animals; Cells, Cultured; Cobalt Radioisotopes; Cysteamine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Leukemia L5178; Leukemia, Experimental; Liver; Mercaptoethylamines; Mice; Organothiophosphorus Compounds; Radiation-Protective Agents; Time Factors; Tissue Extracts | 1983 |
Differential antimutagenicity of WR-1065 added after irradiation in L5178Y cell lines.
Topics: Animals; Antimutagenic Agents; DNA; DNA Repair; Leukemia L5178; Mercaptoethylamines; Mice; Mice, Inbred DBA; Thymidine Kinase; Tumor Cells, Cultured | 1999 |
Antimutagenicity of WR-1065 in L5178Y cells exposed to accelerated (56)Fe ions.
Topics: Animals; Antimutagenic Agents; DNA; Iron Radioisotopes; Leukemia L5178; Mercaptoethylamines; Mutation; Radiation-Protective Agents; Tumor Cells, Cultured | 2002 |